Overexpression of epithelial growth factor receptor (EGFR) predicts better response to neo-adjuvant chemotherapy in patients with triple-negative breast cancer
about
Androgen receptor, EGFR, and BRCA1 as biomarkers in triple-negative breast cancer: a meta-analysisCorrelation between epidermal growth factor receptor and tumor stem cell markers CD44/CD24 and their relationship with prognosis in breast invasive ductal carcinoma.Methylation of tumor suppressor genes is related with copy number aberrations in breast cancerEffect of neoadjuvant chemotherapy in patients with triple-negative breast cancer: A meta-analysis.EGFR Gene Amplification and Protein Expression in Invasive Ductal Carcinoma of the Breast.EGFR expression is associated with cytoplasmic staining of CXCR4 and predicts poor prognosis in triple-negative breast carcinomas.BRCA1-IRIS overexpression promotes and maintains the tumor initiating phenotype: implications for triple negative breast cancer early lesions.Triple negative breast cancer chemosensitivity and chemoresistance: current advances in biomarkers indentification.Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy.Determination of HER2 and p53 Mutations by Sequence Analysis Method and EGFR/Chromosome 7 Gene Status by Fluorescence in Situ Hybridization for the Predilection of Targeted Therapy Modalities in Immunohistochemically Triple Negative Breast CarcinomaPP2A as the Main Node of Therapeutic Strategies and Resistance Reversal in Triple-Negative Breast Cancer.Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients.A meta-analysis of biomarkers for the prognosis of triple-negative breast cancer patients.
P2860
Q26823419-6FEBC170-09F5-4D9E-8D69-41184743AA0AQ34580487-5480AFF2-4813-45BA-8FC3-E7B294940DF1Q34991280-9F1693A6-6784-4C24-9D0C-818CBEB8F146Q35759050-B9B9DC38-32FE-44B5-94A0-23E2BACF6EECQ36824370-6352AD3B-006D-4639-ABF4-01E06DD8C304Q37701050-AB17C8A6-14C4-458D-B42C-F5A4D17E512BQ37705790-7226AE0F-949C-4FCD-A033-9E8F60C58BBBQ38647802-E2754FBE-62B8-48F6-B02D-30DFD137D9AFQ41859828-0CD9FEEB-4010-459B-AB89-F09AB40CF858Q42478126-C6F1375C-539F-40AE-9825-FF2576B30830Q47271622-0C342030-D01B-44BD-BCA6-7B6E8D504C5BQ48364519-1093F88E-8002-481A-8907-ED2EBC1C9BC7Q51684386-ECEE7837-E739-4B8E-AD6B-AF90A51BCA02
P2860
Overexpression of epithelial growth factor receptor (EGFR) predicts better response to neo-adjuvant chemotherapy in patients with triple-negative breast cancer
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Overexpression of epithelial g ...... triple-negative breast cancer
@ast
Overexpression of epithelial g ...... triple-negative breast cancer
@en
type
label
Overexpression of epithelial g ...... triple-negative breast cancer
@ast
Overexpression of epithelial g ...... triple-negative breast cancer
@en
prefLabel
Overexpression of epithelial g ...... triple-negative breast cancer
@ast
Overexpression of epithelial g ...... triple-negative breast cancer
@en
P2093
P2860
P1476
Overexpression of epithelial g ...... triple-negative breast cancer
@en
P2093
Dengbin Wang
Jianfang Li
Kunwei Shen
Louis W C Chow
Weiguo Chen
P2860
P2888
P356
10.1186/1479-5876-10-S1-S4
P478
10 Suppl 1
P577
2012-09-19T00:00:00Z
P6179
1000467795